VIVE stock: buy or sell?
February 21st, 2020
Should I buy VIVE stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Viveve Medical stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Viveve Medical stock a buy?
Banks and financial institutions publish stock ratings everyday.Unfortunately, we couldn't find any rating for VIVE stock for the last month.
VIVE stock analysis
After sliding a frightening -25.00% yesterday, Viveve Medical closed today at $1.49 and rocketed a wonderful 3.47%.
After sliding a frightening -25.00% yesterday, Viveve Medical closed today at $1.49 and rocketed a wonderful 3.47%. From a daily perspective, VIVE is in a short term uptrend after plotting its last bottom ($0.95, on Feb 7th) higher than the previous bottom, and its last top ($2.09, on Feb/19) also over the previous top. Now trading in between its last bottom and last top VIVE might consolidate in a plain range, waiting to break out over $2.09 or down under $0.95.
Viveve Medical shares boosted 26.27% this week, ending at $1.49. Late January VIVE collapsed a scary -15.15% in just one week.
In a weekly time frame, Viveve Medical stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, VIVE might consolidate in a flat-base, waiting to break out over or down under . Since last week when VIVE stock price broke up the SMA10w line, it gained $0.52 (53.61%).
VIVE stock price history
VIVE IPO was on June 14th, 2016 at $500.00 per share1. Since then, VIVE stock lost a -99.70%, with a yearly average of -33.20%.
1: Adjusted price after possible price splits or reverse-splits.
VIVE stock historical price chart
VIVE stock reached 52-week highs at $115.00, and all-time highs 2017-04-17 with a price of 1116.
VIVE stock price targetNobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we have not found any price target for Viveve Medical stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareViveve Medical reported nice results for 2018-Q4 on March. Viveve Medical stepped up Earnings per Share (EPS) by 8.60%, beating analysts consensus of $-0.35. Viveve Medical posted $-0.38.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Viveve Medical annual sales rocketed an outstanding 21.12% to $18.52 M dollars from $15.29 marked in 2017. When comparing 2018 vs 2017, by contrast, profit margin (that is, the net income divided by revenues) collapsed a -28.17% to -269.92%.
|2013||$1.27 M||-||$3.50 M275.6%||-|
|2014||$0.09 M||-92.91%||$-6.18 M-6866.7%||-276.57%|
|2015||$1.45 M||1,507.78%||$-12.43 M-858.7%||101.07%|
|2016||$7.14 M||393.50%||$-20.11 M-281.6%||61.85%|
|2017||$15 M||114.09%||$-36.96 M-241.8%||83.78%|
|2018||$19 M||21.12%||$-49.98 M-269.9%||35.23%|
Quarterly financial resultsViveve Medical posted $4.47 million in revenues for 2018-Q4, a -7.24% less compared to previous quarter. Reported quarter earnings marked $-13.49 million with a profit margin of -301.70%. Profit margin plunged a -46.48% compared to previous quarter when profit margin was -255.22%. When comparing revenues to same quarter last year, Viveve Medical sales marked a hair-raising drop down and collapsed a -12.33%. Looking back to recent quarterly results, Viveve Medical posted 2 negative quarters in a row.
|2017-Q1||$3 M||-||$-6.70 M-220.4%||-|
|2017-Q2||$3 M||1.32%||$-10.43 M-338.6%||55.67%|
|2017-Q3||$4 M||32.14%||$-9.62 M-236.2%||-7.81%|
|2017-Q4||$5 M||25.33%||$-10.22 M-200.4%||6.33%|
|2018-Q1||$4 M||-27.48%||$-12.67 M-342.5%||23.91%|
|2018-Q2||$6 M||49.36%||$-11.52 M-208.4%||-9.10%|
|2018-Q3||$5 M||-12.74%||$-12.30 M-255.2%||6.84%|
|2018-Q4||$4 M||-7.24%||$-13.49 M-301.7%||9.66%|
Viveve Medical ownershipWhen you are planning to invest in shares of a company, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Viveve Medical, 0.32% of all outstanding shares are owned by its staff.
In case of Viveve Medical stock, 18.28% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for VIVE stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Viveve Medical:
|Market cap||$5.1 M|
|Total shares||3.4 M|
|Float shares||1.4 M|
|- Institutional holdings (%)||18.3%|
|- Insider holdings (%)||0.3%|
|Shares in short selling||0.0%|
|Friday, February 21st, 2020|
|Day range||$1.34 - $1.62|
|Average true range||$0.21|
|50d mov avg||$1.03|
|100d mov avg||$2.25|
|200d mov avg||$16.16|
Viveve Medical performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. We picked as the bechmarking frame for Viveve Medical stock.